NUKLEINSÄUREHERSTELLUNG

European patent · EP2281035 · In force

Register entry

Publication number
EP2281035
Application number
EP09730379
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 9, 2009
Published
Feb 9, 2011
Granted
Jan 21, 2015
Protection ends at the latest
Apr 8, 2029
Next annual fee due
Apr 30, 2027
IPC classes
C12N 9/12 (2006.01)
C12N 15/10 (2006.01)
Priority
GB 0806562 10.04.2008
PCT application
PCT/EP2009/054329 09.04.2009
PCT publication
WO2009/125006 15.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Mar 31, 2015

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 31.03.2015

  6. Jan 21, 2015

    Granted

    Published in Swissreg on 21.01.2015

Parties

Holder

Thermo Fisher Scientific Baltics UAB

V.A. Graiciuno 8, 02241 Vilnius, LT

Agent

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3000 Bern 25

Inventor

JANULAITIS, Arvydas

LT-08122 Vilnius, LT

SKIRGAILA, Remigijus

LT-03103 Vilnius, LT

SIKSNIENE, Dangira

LT-03127 Vilnius, LT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.